At the Stem Cells Transplant Institute, we use human mesenchymal umbilical cord stem cells (hMUCSs) for the treatment of neuropathy.
Neuropathies are characterized by damage to the nerves.
Diabetic neuropathy is the most common chronic complication of diabetes. According to the National Institute of Diabetes and Digestive and Kidney Disease, diabetic neuropathy affects 60-70% of people with type 1 and type 2 diabetes.
Diabetic neuropathy is a common and serious diabetic condition that damages the nerves throughout your body due to high levels of blood sugar (glucose). The symptoms of diabetic neuropathy can range from mild to disabling and will depend on which nerves are damaged.
Other causes of neuropathy include:
You can have one or more of the four types of neuropathy. Neuropathies can be confusing, difficult to diagnose accurately, and extremely painful. Diabetic neuropathy can lead to other serious medical conditions including:
There are many causes of neuropathy, including diabetes, chemo-induced neuropathy, genetics, inflammatory infections, auto-immune diseases, protein abnormalities, toxic chemicals, poor nutrition, alcoholism, medications and kidney failure.
The precise cause of diabetic neuropathy is still unclear but scientists believe it is due to high levels of blood sugar. Other contributing factors include inflammation, high cholesterol levels, high triglycerides, elevated blood pressure, smoking and obesity. Evidence suggests that the nerve damage begins early in the disease and individuals diagnosed with prediabetes already have some nerve damage. Diabetic neuropathy affects children, teens and adults.
Research shows that stem cells may improve neuropathy by directly modulating both angiogenesis (the physiological process through which new blood vessels form) and myelination (process of forming a myelin sheath around a nerve to allow nerve impulses to move more quickly).
There are currently 41 studies listed on ClinicalTrials.gov evaluating the safety and or efficacy of stem cells for the treatment of diabetic nueropathies. https://clinicaltrials.gov/ct2/results?cond=Diabetic+Neuropathies&term=stem+cell+therapy&cntry=&state=&city=&dist=
Mesenchymal stem cells are self-renewing cells that can be found in almost all organs and tissues including; bone marrow, adipose tissue, umbilical cord blood, compact bone, and other tissues.
Based on clinical research, the Stem Cells Transplant Institute in Costa Rica recommends the use of umbilical cord derived mesenchymal stem cells for the treatment of diabetic neuropathy.
We use only umbilical cord stem cells that are derived exclusively from umbilical cord donations.
The umbilical cord stem cells from are collected after informed consent has been given by the parent, or parents, and only after the delivery of the baby.
The collection follows strict ethical protocols ensuring the stem cells are from safe, reliable sources using a non-invasive, simple and painless procedure. Once collected, the cord blood is then screened for disease
Costa Rica has one of the best healthcare systems in world and is ranked among the highest for medical tourism.
Using the most advanced technologies, the team of experts at The Stem Cells Transplant Institute believes in the potential of stem cell therapy for the treatment of diabetic neuropathy.
We are committed to providing personalized service and the highest quality of care to every patient.
If you suffer from neuropathy or diabetic neuropathy, contact the Stem Cells Transplant Institute to learn more about the benefits of stem cell therapy.